Investors and Media
4D-310 INGLAXA Phase 1/2 Clinical Data Conference Call
February 22, 2023 at 4:30 PM EST
About 4DMT
Our 4DMT genetic medicine engine holds the potential to generate transformative therapies that have the power to improve patient lives, or even cure disease.
© 2023 4D Molecular Therapeutics. All rights reserved.